# Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IGlarLixi

> **NCT03130426** · PHASE3 · COMPLETED · sponsor: **Population Health Research Institute** · enrollment: 161 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** iGlarLixi
- **DRUG:** Insulin Glargine
- **DRUG:** Metformin
- **BEHAVIORAL:** Lifestyle therapy

## Key facts

- **NCT ID:** NCT03130426
- **Lead sponsor:** Population Health Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-27
- **Primary completion:** 2019-06-30
- **Final completion:** 2020-09-30
- **Target enrollment:** 161 (ACTUAL)
- **Last updated:** 2020-11-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03130426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03130426, "Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IGlarLixi". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03130426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*